Surveillance Study of NovoRapid® for New Drug Re-examination
NCT01490112
·
clinicaltrials.gov ↗
COMPLETED
Status
1239
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Interventions
DRUG:
insulin aspart
Sponsor
Novo Nordisk A/S